July 24, 2012
Novartis Pharmaceuticals Corp. went after Lupin Ltd. in New Jersey federal court on Friday, accusing its pharmaceutical rival of infringing the patent used in hypertension treatment Diovan HCT in its attempts to market a competing generic version of the drug.